A new synthetic approach for pyrazolo[1,5-a]pyrazine-4(5H)-one derivatives and their antiproliferative effects on lung adenocarcinoma cell line

Mol Divers. 2022 Feb;26(1):113-124. doi: 10.1007/s11030-020-10161-8. Epub 2021 Jan 2.

Abstract

Starting from the 3,5-dimethyl pyrazole ring and acetophenone derivatives, five different N-propargylated C-3 substituted pyrazoles were obtained. These derivatives were reacted with different amine derivatives using Cs2CO3 in methanol and 11 different pyrazolo [1,5-a] pyrazine-4(5H)-one derivatives were obtained, which are not found in the literature. The cytotoxic effects of these derivatives in the A549 cell line were investigated. The 160 µM concentration of two derivatives was found to increase cell death rate to 50%, and two derivatives increased cell death rate by up to 40%. The structure-activity relationship (SAR) study revealed an amide group with a long alkyl chain and benzene ring with a p-CF3 group could be important for efficiency. With theoretical ADMET studies of pyrazolopyrazine derivatives, pharmacokinetic phases were predicted to be suitable.

Keywords: ADMET; Alkyne cyclization; Allene; KRAS mutant lung cancer; Lung adenocarcinoma; Pyrazole.

MeSH terms

  • A549 Cells
  • Adenocarcinoma of Lung* / drug therapy
  • Antineoplastic Agents* / pharmacology
  • Cell Line, Tumor
  • Cell Proliferation
  • Humans
  • Molecular Structure
  • Pyrazines / pharmacology
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Pyrazines

Grants and funding